Starting with Reduced-Risk Nicotine Expanding in Chronic Obstructive Pulmonary Disease and Other Therapeutic Areas BOONE, N.C.--(BUSINESS WIRE)--Pneuma Respiratory, a med-tech and pharmaceutical company dedicated to advancing inhaled respiratory therapeutics, is introducing new transformational approaches to respiratory health to improve the standard of care for millions of patients worldwide. Focusing on treatments for smoking-related lung conditions, Pneuma has developed a novel aerosol generation technology that provides a more efficient way to deliver medication to the lungs. Pneuma is accelerating its goal to improve respiratory health through the creation of strategic partnerships, aim... [Read more]